A bill to direct the Food and Drug Administration to prevent the importation of counterfeit, unapproved, misbranded, or adulterated drugs from the People's Republic of China or other foreign countries, to establish enhanced safeguards for imported drug products, and for other purposes.

Ted Budd

Republican · NC · Senator

Source: Congress.gov · FEC

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2026-07-21

Source: Congress.gov

The FDA would be required to strengthen inspections and safety checks on medicines imported from China and other countries to block fake, contaminated, or unapproved drugs from entering the U.S. market. This would protect patients and consumers by ensuring imported medications meet American safety standards before reaching pharmacies and hospitals. The bill also sets up new procedures to identify and stop dangerous or counterfeit drugs at the border.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

• S5063A bill to establish in the Department of State a Foundational Infrastructure for Responsible Use of Small Modular Reactor Technology program, and for other purposes.
  Referred to Committee · 2026-07-22
• S1759Supersonic Aviation Modernization Act
  Referred to Committee · 2026-07-22
• SRES803A resolution congratulating the 2025-2026 Carolina Hurricanes for winning the Stanley Cup.
  Introduced · 2026-07-14
• S4873Promoting Human Flourishing in Foreign Assistance Act
  Referred to Committee · 2026-06-23